메뉴 건너뛰기




Volumn 2, Issue 2, 2002, Pages 17-19

Are concerns about the ethics of placebos a stalking horse for other issues?

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

EID: 0036516743     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1162/152651602317533569     Document Type: Note
Times cited : (4)

References (9)
  • 1
    • 0035191281 scopus 로고    scopus 로고
    • Modeling suicide risk in primary care primary affective disorders
    • Boardman A. P. and D. Healy. 2001. Modeling suicide risk in primary care primary affective disorders. European Psychiatry 16: 400-05.
    • (2001) European Psychiatry , vol.16 , pp. 400-405
    • Boardman, A.P.1    Healy, D.2
  • 2
    • 33845902420 scopus 로고
    • FDA review and evaluation of clinical data original NDA 20-021
    • 19 June 1991
    • Brecher, M. 1991. FDA review and evaluation of clinical data original NDA 20-021, Paroxetine Safety Review, 19 June 1991.
    • (1991) Paroxetine Safety Review
    • Brecher, M.1
  • 3
    • 0031065337 scopus 로고    scopus 로고
    • Caring about risks: Are severely depressed patients competent to consent to research?
    • Elliott C. 1997. Caring about risks: Are severely depressed patients competent to consent to research? Archives of General Psychiatry 54:113-16.
    • (1997) Archives of General Psychiatry , vol.54 , pp. 113-116
    • Elliott, C.1
  • 4
    • 0034033736 scopus 로고    scopus 로고
    • Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials
    • Khan, A., H. A. Warner, and W. A. Brown. 2000. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials. Archives of General Psychiatry 57:311-17.
    • (2000) Archives of General Psychiatry , vol.57 , pp. 311-317
    • Khan, A.1    Warner, H.A.2    Brown, W.A.3
  • 5
    • 0035180445 scopus 로고    scopus 로고
    • The scientific and ethical basis for placebocontrolled trials in depression and schizophrenia: An FDA perspective
    • Laughren, T. P. 2001. The scientific and ethical basis for placebocontrolled trials in depression and schizophrenia: An FDA perspective. European Psychiatry 16:418-23.
    • (2001) European Psychiatry , vol.16 , pp. 418-423
    • Laughren, T.P.1
  • 8
    • 0032518958 scopus 로고    scopus 로고
    • Suicide mortality among patients treated for depression in an insured population
    • Simon, G. E., and M. VonKorff. 1998. Suicide mortality among patients treated for depression in an insured population. American Journal of Epidemiology 147:155-60.
    • (1998) American Journal of Epidemiology , vol.147 , pp. 155-160
    • Simon, G.E.1    Vonkorff, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.